Pharmacological Group: Bronchodilators, Active Ingredient: Aminophylline, Pharmaceutical Form: Tablet, Concentration / Dosage: 100, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Antidepressants And Mood Stabilizers, Active Ingredient: Citalopram, Pharmaceutical Form: Tablet Coated, Concentration / Dosage: 20, Volume: N/A, Presentation: N/A, Accessory: N/A, Pharmacological Group: Hydroelectrolytic Solutions And Correctors Of Acid-Base Balance, Active Ingredient: Sodium Chloride Sterile And Non-Pyrogenic Solution, Pharmaceutical Form: Liquid, Concentration / Dosage: 0.9, Unit: %, Volume: 1000Ml, Presentation: Closed System, Volume: 100Ml, Pharmacological Group: Diuretics, Active Ingredient: Spironolactone, Concentration / Dosage: 25, 19/03/2026 - 15:10:35, Pharmacological Group: Anticonvulsants, Active Ingredient: Sodium Phenobarbital, Active Ingredient: Fluoxetine Hydrochloride, Pharmaceutical Form: Capsule, Active Ingredient: Imipramine Hydrochloride, Pharmacological Group: Hypoglycemic Agents, Active Ingredient: Nph Human Insulin, Pharmaceutical Form: Injectable Suspension, Unit: Iu/Ml, Volume: 10Ml, Presentation: Ampoule Vial, Active Ingredient: Levetiracetam, Concentration / Dosage: 750, Pharmacological Group: Antiemetics And Prokinetics, Active Ingredient: Ondansetron Hydrochloride, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 2, Unit: Mg/Ml, Volume: 4Ml, Presentation: Ampoule, Pharmacological Group: Antineoplastics, Active Ingredient: Pamidronate Disodium, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 90, Accessory: Diluent 10 Ml, Supply Form: Unit
